Segundo Gonzalez Selected Research

Segundo Gonzalez Research Topics

Disease

16	Neoplasms (Cancer) 04/2021 - 05/2007
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2021 - 08/2012
4	Leukemia 01/2017 - 10/2010
3	Hematologic Neoplasms (Hematological Malignancy) 04/2021 - 01/2013
2	Multiple Myeloma 01/2020 - 01/2013
2	Disease Progression 01/2014 - 10/2010
2	Celiac Disease (Celiac Sprue) 03/2006 - 02/2002
2	Ankylosing Spondylitis 01/2006 - 08/2002
1	Squamous Cell Carcinoma of Head and Neck 11/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 12/2018
1	Infections 01/2017
1	Polyploidy 02/2016
1	Carcinogenesis 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 04/2013
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2013
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2013
1	Tumor Lysis Syndrome 01/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2013
1	Relapsing-Remitting Multiple Sclerosis 04/2008
1	Multiple Sclerosis 04/2008
1	Autoimmune Diseases (Autoimmune Disease) 04/2008
1	Psoriatic Arthritis 01/2006
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2006
1	Spondylarthropathies 08/2002

Drug/Important Bio-Agent (IBA)

8	LigandsIBA 01/2017 - 05/2007
4	Pharmaceutical PreparationsIBA 02/2016 - 01/2013
4	micaIBA 04/2013 - 03/2006
3	Lenalidomide (CC 5013)FDA Link 01/2018 - 01/2013
2	Monoclonal AntibodiesIBA 04/2021 - 04/2020
2	Immune Checkpoint InhibitorsIBA 04/2021 - 01/2017
2	Messenger RNA (mRNA)IBA 11/2020 - 01/2015
2	CytokinesIBA 04/2020 - 02/2016
2	Chimeric Antigen ReceptorsIBA 04/2020 - 09/2019
2	Proteins (Proteins, Gene)FDA Link 09/2019 - 08/2012
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2006 - 08/2002
1	relatlimabIBA 04/2021
1	Immunomodulating AgentsIBA 04/2021
1	LectinsIBA 11/2020
1	Granzymes (Granzyme)IBA 05/2020
1	PerforinIBA 05/2020
1	Death Domain ReceptorsIBA 05/2020
1	AntigensIBA 04/2020
1	daratumumabIBA 01/2020
1	EnzymesIBA 01/2020
1	BI-1347IBA 01/2020
1	AntibodiesIBA 09/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2018
1	InterferonsIBA 01/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017
1	Casein Kinase II (Casein Kinase 2)IBA 01/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	HMGB1 Protein (HMG1)IBA 01/2016
1	NK Cell Lectin-Like Receptor Subfamily KIBA 04/2015
1	demycarosyl-3D-digitoxosylmithramycin SKIBA 01/2015
1	Rituximab (Mabthera)FDA Link 01/2014
1	Glycogen Synthase (Synthase I)IBA 04/2013
1	Sp1 Transcription FactorIBA 04/2013
1	Endoplasmic Reticulum Chaperone BiPIBA 08/2012
1	Dihydrotachysterol (AT 10)IBA 10/2010
1	MICB antigenIBA 04/2008
1	HLA-C Antigens (HLA-C)IBA 01/2006
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2006
1	HLA-DRB4 Chains (HLA DRB4)IBA 02/2002
1	HLA-DQ8 antigenIBA 02/2002

Therapy/Procedure

6	Therapeutics 04/2021 - 01/2017
4	Immunotherapy 04/2020 - 04/2015
2	Hematopoietic Stem Cell Transplantation 04/2020 - 09/2019
1	Ligation 09/2019
1	Time-to-Treatment 01/2014
1	Immunomodulation 01/2014